Russo A, et al. - The effectiveness of an intravitreal dexamethasone (Dex) implant 0.7 mg vs intravitreal ranibizumab (Ra) was assessed for the treatment of radiation maculopathy with macular edema secondary to plaque brachytherapy in choroidal melanoma. For macular edema secondary to plaque brachytherapy for uveal melanoma, both Ra and Dex were seen to be effective treatments. In order to achieve anatomical and functional improvement, Dex-treated patients required fewer injections.